Mangalam Drugs and Organics News

Mangalam Drugs Seeks Shareholder Nod for Director Re-appointment

Mangalam Drugs & Organics has initiated a postal ballot to re-appoint Shri Praveen Saxena as Independent Director for a second five-year term from March 21, 2026 to March 20, 2031.

Mangalam Drugs Posts ₹4,381 Lakh Net Loss in FY26

Mangalam Drugs & Organics reported a standalone net loss of Rs. 4,381.42 lakhs for FY26, reversing a net profit of Rs. 692.43 lakhs in FY25, as revenue fell sharply to Rs. 23,213.27 lakhs.

Mangalam Drugs Board Meet Set for May 14, 2026

Mangalam Drugs & Organics schedules board meeting on May 14, 2026 to consider audited financial results for Q4 and full year ended March 31, 2026.

Mangalam Drugs Files Revised CS Resignation Disclosure

Mangalam Drugs & Organics submits revised disclosure regarding Company Secretary Anuradha Pandey's resignation effective March 29, 2026, citing administrative oversight for delayed filing.

Mangalam Drugs Files Revised Disclosure on CS Resignation

Mangalam Drugs & Organics submits revised disclosure regarding Company Secretary Anuradha Pandey's resignation effective March 29, 2026, citing administrative oversight for delayed filing.